Innovative Medical Solutions VIVO is actively advancing non-invasive cardiac mapping and ablation technologies, demonstrated by recent clinical publications and industry presentations, indicating strong market acceptance and potential for expanding sales within the electrophysiology and cardiology sectors.

Geographic Expansion The company has begun receiving purchase orders from the Middle East, specifically Qatar, suggesting opportunities to penetrate additional international markets through distributor partnerships and localized sales efforts.

Clinical Validation VIVO's products have been validated through multiple clinical studies and presentations at major cardiology conferences, offering sales teams credibility and strong value propositions to hospitals, clinics, and healthcare providers seeking proven, effective solutions.

Partnership Opportunities Partnerships with hospitals like Hamad Medical in Qatar and participation in industry meetings highlight potential collaborations for joint adoption programs, clinical trials, and long-term sales channels in diverse healthcare settings.

Adjacent Market Potential Related industries such as regenerative wound care and antimicrobial therapies, exemplified by Omeza’s success, open cross-selling opportunities for VIVO's technology in wound management, chronic care, and antimicrobial applications.